ViaGen, Inc. – Trademark Portfolio

Entity Type: 03

ViaGen, Inc. has 15 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO). Filings span 5 Nice Classification classes, led by Class 44 (Medical Services) and Class 42 (Computer & Scientific). This trademark owner is based in Austin, TX.

12357-A Riata Trace Parkway, Suite 100

Austin, TX 78727

15 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Trademark Classifications

ViaGen, Inc.'s trademark portfolio spans 5 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

44
Medical Services (7 filings)

Medical services; veterinary services; hygienic and beauty care for human beings or animals

42
Computer & Scientific (5 filings)

Scientific and technological services; industrial analysis and research services

29
Meats & Processed Foods (5 filings)

Meat, fish, poultry and game; meat extracts; preserved, frozen, dried and cooked fruits

31
Natural Agricultural Products (4 filings)

Raw and unprocessed agricultural, aquacultural, horticultural and forestry products

1
Chemicals (2 filings)

Chemical products for industry, science, photography, agriculture, horticulture and forestry

Frequently Asked Questions

How many trademarks does ViaGen, Inc. have?

ViaGen, Inc. has 15 U.S. trademarks filed with the USPTO.

What trademark classes does ViaGen, Inc. file in?

ViaGen, Inc. files trademarks across 5 Nice Classification classes. The most active classes are Class 44 (Medical Services), Class 42 (Computer & Scientific), Class 29 (Meats & Processed Foods), Class 31 (Natural Agricultural Products), Class 1 (Chemicals). Class 44 covers medical services; veterinary services; hygienic and beauty care for human beings or animals.

What is ViaGen, Inc.'s trademark registration success rate?

ViaGen, Inc. has a 0% trademark registration rate, with 0 out of 15 resolved applications resulting in successful registration. Currently, 0 applications are pending review.